Organic Active Ingredients TRIZ Cases

Pre-administering NSAIDs before lipid nanoparticle infusion reduces inflammatory mediator concentration and prevents hypertension.

A two-step chemical induction system using rimiducid and rapamycin to trigger apoptosis in therapeutic cells expressing inducible caspase polypeptides.

A CCR2-targeting copper nanocluster delivers chemotherapeutic agents to pancreatic cancer cells.

Isotopic substitution stabilizes transthyretin, preventing amyloid fibril deposition in organs.

Sustained-release glucose pellets eliminate frequent dosing and digestive intolerance from raw corn starch therapy, ensuring stable blood glucose levels.

Recombinant constructs reduce HLA-I expression to protect transplanted cells from immune rejection, eliminating the need for complex donor matching.

Pyridine carbamate compounds target GluN2B receptors, addressing the lack of specific modulators for neurological disorders.

Hydrophobic pockets in PEGylated telodendrimers isolate Amphotericin B monomers, reducing nephrotoxicity while maintaining antifungal efficacy.

Codon optimization of the spike protein gene resolves low expression efficiency in human cells while maintaining safe, simplified manufacturing.

Fusing six immunogenic fragments into a single polypeptide overcomes weak immune responses from individual recombinant proteins while maintaining safety.

Tannin-chitosan composite films dissolve rapidly to release active pharmaceutical ingredients.

dsRNA agents inhibit HMGB1 expression to reduce liver inflammation and fibrosis in non-alcoholic fatty liver disease.

Pyrrolidine compounds inhibit alpha v beta 6 integrin to block TGFbeta activation.

Ester and carbamate prodrug derivatives enhance oral bioavailability of protease inhibitors, resolving rapid metabolism issues that limit antiviral efficacy.

Intravenous decidua stromal cells reduce cytokine storms and improve oxygen saturation in acute respiratory distress syndrome.

Lipid nanoparticles deliver mRNA encoding botulinum toxin to reduce antibody formation risks while enabling localized protein expression.

A nicotine pouch filler with release control excipients and a multi-fiber packaging material modulate nicotine diffusion into saliva.

Low molecular weight marine algal glycoproteins stimulate endogenous insulin secretion to maintain stable glucose levels after treatment withdrawal.

Polyoxysorbitan esters and a base accelerate ibuprofen solubilization, overcoming slow release rates of conventional formulations.

Oral small molecule inhibitors replace monoclonal antibodies to lower plasma LDL cholesterol via targeted PCSK9 reduction.

Suppressing POLQ reduces alternative non-homologous end joining interference, improving Cas9-mediated DNA editing precision.

Systematic variation of R1 and R2 substituents on the irciniastatin core improves anticancer selectivity while managing synthesis complexity.

Specific heterocyclic compounds inhibit IDO1 enzyme activity, addressing insufficient efficacy of current therapeutic agents in treating cancers.

RALA peptide mediates intracellular mRNA delivery to prime CD8+ T cells, treating existing HPV infections.

N-alkyl-N-heteroarylsulfonamide compounds disrupt the HIF-1 transcriptional complex to overcome tumor resistance and pleiotropic effects.

Cationic liposomes stabilize RNA via electrostatic binding, reducing viral vector toxicity while maintaining high encapsulation efficiency.

Bangia fusco-purpure and Lactobacillus fermentation produces a supernatant with high alpha-glucosidase inhibition rates.

Standardized licorice extract with specific glycyrrhizin to liquiritin ratios addresses the lack of active component confirmation in herbal liver treatments.

Yukmijihwang-tang extract reduces metformin-induced liver and kidney damage while improving bioavailability.

Biodegradable ionizable lipids form delivery vehicles that penetrate cell membranes, resolving suboptimal transfection efficiency in hard-to-transfect cells.

Cyclic glycine-proline biomarker tracks active insulin-like growth factor 1 levels using blackcurrant anthocyanin extracts.

A Bacillus coagulans MTCC 5856 and anthocyanin composition restores normal mucosal architecture in the gastrointestinal tract.

Segmented amphipathic peptide nanoparticles convert cold tumors into hot tumors by inducing immunogenic cell death via visible light activation.

Hydroxyalkylated starch targets neoplasm-associated macrophages to reduce tumor growth while avoiding the toxic side effects of conventional chemotherapy.

Segmenting BET inhibitors into specific tricyclic structures resolves the trade-off between therapeutic effectiveness and limited treatment options.

Oxazolidinone derivatives inhibit HCV NS5A protein, reducing side effects and improving treatment efficacy for difficult patient groups.

Targeting nuclear PC4 prevents cancer recurrence by blocking DNA repair while reducing toxicity to normal cells.

A preservative-free l-epinephrine pharmaceutical formulation uses controlled pH and inert atmosphere packaging to maintain potency.

Anti-PMEL17 antibodies resolve specificity and efficacy trade-offs by targeting PMEL17-positive cancer cells with high affinity.

Chelating agents remove heavy metal ions while ethanol precipitation separates fucoidan from bacterial contaminants, improving extract purity.

Bioadhesive nanoparticles form covalent bonds with tumor cells to address systemic toxicity and limited efficacy of topical chemotherapies.

Volatile siloxane vehicle delivers vitamin E acetate to reduce crust resolution time from 15-20 days to 7-10 days.

Positively-charged cationic liposomes enhance cellular uptake of immune modulators to stimulate anti-tumor immunity.

Natural polyphenolic compounds cinnamtannin B1 and D1 decrease CD274 gene expression, replacing complex antibody therapies with oral administration.

Pyrrolidine compounds antagonize orexin receptors, addressing the lack of effective treatments for sleep disorders and insomnia.

Polycarbonate-ester polymers protect kojic acid from thermal degradation while enabling controlled hydrolytic release for stable personal care applications.

Solvent-based crystallization yields a non-hygroscopic crystal form that resolves polymorphic variability and improves drug stability.

Flagella beating drives algae-based microrobots through biological barriers, evading macrophage phagocytosis to treat pulmonary infections.

Vaccinium bracteatum leaf extract reduces immobility time and stress hormone levels, addressing the lack of safe natural resources for depression treatment.